Galvin, Gaustad & Stein, LLC Bristol Myers Squibb CO Transaction History

Galvin, Gaustad & Stein, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $770,098 - $923,416	-12,526 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $651,658 - $759,680	-12,151 Reduced 49.24%	12,526 $781,000
Q3 2021 Oct 29, 2021	SELL	$59.17 - $69.31 $113,133 - $132,520	-1,912 Reduced 7.19%	24,677 $1.46 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $371 - $404	6 Added 0.02%	26,589 $1.78 Million
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $18,573 - $20,889	-313 Reduced 1.16%	26,583 $1.68 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $1.55 Million - $1.76 Million	26,896 New	26,896 $1.67 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Galvin, Gaustad & Stein, LLC, based on Form 13F filings with the SEC.

Stay updated on Galvin, Gaustad & Stein, LLC with notifications on news.